Showing results (1181-1190 of 1,360) with videos related to
Sort By:
Pageof 136
International Journal of Cancer|March 15, 1994
Analysis of cytomorphologically abnormal cervical scrapes for the presence of 27 mucosotropic human papillomavirus genotypes, using polymerase chain reactionA M de Roda Husman, J M Walboomers, C J Meijer, et al.Anaesthesia|August 28, 2025
Effects of anaesthesia and surgery on sleep-wake timing and subjective sleep quality in children: an observational studyArjen J G Meewisse, Sharon J Meijer, Kee Fong Choi, et al.Emerging Infectious Diseases|June 25, 2025
Emergence of Flucytosine-Resistant Candida tropicalis Clade, the NetherlandsFatima Zohra Delma, Bram Spruijtenburg, Jacques F Meis, et al.Medical Mycology Case Reports|July 18, 2025
Disseminated sporotrichosis caused by <i>Sporothrix brasiliensis</i> with testicular involvementRegielly Caroline Raimundo Cognialli, Matheus Hideki Taborda, Bruno Hassunuma Carneiro, et al.British Journal of Cancer|October 10, 2013
Somatic copy number changes in DPYD are associated with lower risk of recurrence in triple-negative breast cancersE Gross, C Meul, S Raab, et al.Journal of Psychopharmacology (Oxford, England)|July 26, 2017
Longitudinal study of hippocampal volumes in heavy cannabis usersL Koenders, V Lorenzetti, L de Haan, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 3, 2020
3-Dimensional target coverage assessment for MRI guided esophageal cancer radiotherapyM R Boekhoff, I L Defize, A S Borggreve, et al.Journal of Surgical Oncology|March 8, 2017
Perioperative chemotherapy versus neoadjuvant chemoradiotherapy for esophageal or GEJ adenocarcinoma: A propensity score-matched analysis comparing toxicity, pathologic outcome, and survivalLucas Goense, Pieter C van der Sluis, Peter S N van Rossum, et al.Cancer Gene Therapy|July 31, 2001
Selective gene delivery toward gastric and esophageal adenocarcinoma cells via EpCAM-targeted adenoviral vectorsD A Heideman, P J Snijders, M E Craanen, et al.Lancet (London, England)|February 9, 1999
Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trialJ B Vermorken, A M Claessen, H van Tinteren, et al.Pageof 136